Since the calendar turned to 2024, we have seen some blockbusters, including Novo Nordisk’s $16.5 billion purchase agreement for Catalent and the closing of Bristol Myers Squibb’s $4.8 billion acquisition of Mirati Therapeutics.
Tag Archive for: mergers and acquisitions
Merger and acquisition activity is on the rise after the biopharma industry moved on from the COVID-19 pandemic, while the role of AI in drug development is reaching new levels.
Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.
Continued fallout from the IRA, heightened antitrust enforcement and the rise of AI will all shape the first wave of biotech mergers and acquisitions coming this year.
Mergers and acquisitions across the pharmaceuticals and life sciences sector will reach a “healthy” level next year, with deals totaling $225 billion to $275 billion, according to professional services firm PwC’s new US Deals 2024 Outlook report.
Merger and acquisition (M&A) activity in the global healthcare sector should continue to rise next year, led by healthcare companies rather than private equity, according to a survey of industry executives.
Abbvie will lift a self-imposed $2 billion limit on acquisitions and mergers placed following a $63 billion deal for Botox maker Allergan in 2020 that shot up its debt, the company’s chief executive officer told the Wall Street Journal.
As the 118th Congress kicks into gear, biopharma industry observers speculate that 2023 may be a challenging year.
The year 2022 was relatively thin for pharma M&A, with deals worth nearly $66 billion being announced by early December. However, drugmakers are primed for a shopping spree in 2023.
The United States is in the early days of a recession and the biotech industry is in a bit of a slump. CEOs can take heart, however, by applying the lessons of previous recessions to business today and understanding what is different about the current situation.
